Multicenter phase 2 study of combined gemcitabine and epirubicin as second-line treatment for patients with advanced ovarian cancer

Viviana Murgia, Roberto Sorio, Claudia Griso, Orazio Caffo, Carmela Arcuri, Antonella Ferro, Alessia Caldara, Simona Scalone, Emilio Arisi, Enzo Galligioni

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Multicenter phase 2 study of combined gemcitabine and epirubicin as second-line treatment for patients with advanced ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences